✦ LIBER ✦

Genentech submits BLA for bevacizumab [Avastin].

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravitreal bevacizumab (Avastin®) for

✍ Pedro Arriola-Villalobos; Juan Donate-López; Cristina Calvo-González; Juan Reche 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 101 KB

Fearful of Avastin's fate, Genentech ask

✍ Ratner, Mark 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 308 KB

Bevacizumab (Avastin) for the Treatment

✍ Jonathan B. Gunther; Michael M. Altaweel 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 423 KB

Bevacizumab (Avastin) for the treatment

✍ Michael N Chilov; John R Grigg; T Justin Playfair 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Targeted therapy with bevacizumab (Avast

✍ Georgios V. Koukourakis; Anastasia Sotiropoulou-Lontou 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

Intravitreal bevacizumab (Avastin) for p

✍ Özkiriş, A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 169 KB